Name: Acute Care
Brand: ECRI
SKU: NIL
Availability: InStock
Rating: 4.6 (5 reviews)

ISMP Newsroom

ISMP

Media Inquiries

For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.

Tous les articles

Press Coverage

Press Coverage

Medication Safety Group Issues Alert on COVID-19 Antiviral

This article appeared on the Becker’s Hospital Review website on January 4, 2022.

Press Coverage

Press Coverage

Making Clinical Trials More Successful

This article appeared on the MedCity News website on December 23, 2021.

Press Coverage

Press Coverage

Beware Flu and COVID Vax Mix-Ups and Other Medication Errors

This article appeared on the MedPage Today website on December 9, 2021.

Press Coverage

Press Coverage

ISMP, TJC Urge Safer Smart Pump Practices

This article appeared on the Specialty Pharmacy Continuum website on November 25, 2021.

Press Coverage

Press Coverage

Disrespectful Behavior in Long Term-Care: New Survey from ISMP

This article appeared on the Annals of Long Term Care website on November 9, 2021.

Press Coverage

Press Coverage

ISMP Warns about Mixing Up Pediatric and Adult COVID-19 Shots

This article appeared on the Beckers Hospital Review website on November 8, 2021.

Stay Connected

Get medication safety news, event invitations and updates straight to your inbox!

Social Media

View the Latest from ECRI

News

HANYS Marketplace partners with ECRI to improve patient safety and reduce preventable harm in healthcare

HANYS Marketplace® has partnered with ECRI, a nonprofit organization advancing the safety and quality of healthcare, to provide New York’s hospitals and health systems with evidence-based solutions...

News

ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award

Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...

News

ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides

The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...

View all